Exozymes Inc.
EXOZ- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0002010788
In the last 90 days, Exozymes Inc. insiders filed 1 open-market purchase and 0 sales; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.05M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Exozymes Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 7 | 6 | −1 |
| Shares | 98.1K | 76.8K | −21.3K (−21.7%) |
| Value | $1.62M | $802.2K | −$816.4K (−50.4%) |
New holders (1)
Institutions that held Exozymes Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 4,474 | $46.8K | 0.00% |
Sold out (2)
Institutions that held Exozymes Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Citadel Advisors LLC | 27,652 | $456.3K |
| BNP Paribas Arbitrage, SA | 2,113 | $34.9K |